ATI Physical Therapy PE Ratio 2020-2023 | ATIP

Current and historical p/e ratio for ATI Physical Therapy (ATIP) from 2020 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. ATI Physical Therapy PE ratio as of May 01, 2024 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

ATI Physical Therapy PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-05-01 4.27 0.00
2023-12-31 6.14 $-31.81 0.00
2023-09-30 8.86 $-56.16 0.00
2023-06-30 9.15 $-81.74 0.00
2023-03-31 12.71 $-98.50 0.00
2022-12-31 15.25 $-126.00 0.00
2022-09-30 50.00 $-99.50 0.00
2022-06-30 70.50 $-153.50 0.00
2022-03-31 94.00 $-280.00 0.00
2021-12-31 169.50 $-245.00 0.00
2021-09-30 190.00 $-245.00 0.00
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.018B $0.699B
ATI Physical Therapy Inc. is a portfolio company of Advent International as well as provider of outpatient physical therapy services. ATI Physical Therapy Inc., formerly known as Fortress Value Acquisition Corp. II, is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.867B 10.20
Quest Diagnostics (DGX) United States $15.351B 15.86
DaVita (DVA) United States $12.191B 16.59
Chemed (CHE) United States $8.599B 26.65
Encompass Health (EHC) United States $8.350B 21.49
Elanco Animal Health (ELAN) United States $6.502B 14.79
Option Care Health (OPCH) United States $5.195B 19.66
RadNet (RDNT) United States $3.584B 97.00
Amedisys (AMED) United States $3.008B 21.31
LifeStance Health (LFST) United States $2.362B 0.00
Astrana Health (ASTH) United States $2.081B 25.98
Addus HomeCare (ADUS) United States $1.574B 23.92
U.S Physical Therapy (USPH) United States $1.530B 39.65
Pennant (PNTG) United States $0.628B 36.68
Aveanna Healthcare Holdings (AVAH) United States $0.433B 0.00
Atai Life Sciences (ATAI) Germany $0.331B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.027B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.012B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00